IP Verse

Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell Function

Patent No. EP4331604 (titled "Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell Function") was filed by F Hoffmann LA Roche on Dec 8, 2009. The application was issued on Jul 23, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZNov 28, 2025ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4331604

F HOFFMANN LA ROCHE
Application Number
EP23214687A
Filing Date
Dec 8, 2009
Status
Granted And Under Opposition
Jan 31, 2025
Publication Date
Jul 23, 2025
External Links
Slate, Register , Google Patents